Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

scientific article published in February 1991

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0140-6736(91)90943-J
P698PubMed publication ID1671232

P50authorMartin RoweQ37376494
Stephen Hamilton-DutoitQ42323196
P2093author name stringL S Young
G Pallesen
P433issue8737
P407language of work or nameEnglishQ1860
P921main subjectEpstein–Barr virusQ6900
P304page(s)320-322
P577publication date1991-02-01
P1433published inThe LancetQ939416
P1476titleExpression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease
P478volume337

Reverse relations

cites work (P2860)
Q617184133D Telomere FISH defines LMP1-expressing Reed–Sternberg cells as end-stage cells with telomere-poor ‘ghost’ nuclei and very short telomeres
Q72838637A 26-year-old man with Hodgkin's disease and rapidly progressive pancytopenia
Q51011838A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses.
Q45771274A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection
Q35121627A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer
Q35872919A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle
Q35831803A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas
Q45736315Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma
Q26782845Adoptive T-Cell Immunotherapy
Q55240614Adult T-Cell Leukaemia-Lymphoma Relapsing as Hodgkin Disease Nodular Sclerosis Subtype.
Q73101619Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease
Q73227618An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin's disease and Reed-Sternberg-like cells in non-Hodgkin's lym
Q42937211Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site
Q40958134Anaplastic large cell lymphoma: update of findings
Q73006577Antiapoptotic marker Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12
Q45879859Antibodies to human herpes virus‐6 and clinical course in patients with Hodgkin's disease
Q45753261Antibody against the Epstein-Barr virus BHRF1 protein, a homologue of Bcl-2, in patients with nasopharyngeal carcinoma
Q73572578Apoptosis of malignant cells in Hodgkin's disease is related to expression of the cdk inhibitor p27KIP1
Q33748089Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo
Q36623027Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease
Q45402221Association between Epstein-Barr virus and Hodgkin's lymphoma in Belgium: a pathological and virological study
Q35833017Association of Epstein-Barr virus with pediatric Hodgkin's disease.
Q36370843Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma
Q35549146B cells under influence: transformation of B cells by Epstein–Barr virus
Q35110895Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases
Q33772230Biology and disease associations of Epstein-Barr virus
Q40548687Biopathologic features of Hodgkin's disease
Q35232770CD23 and the Epstein-Barr virus
Q45400120CD4(+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission
Q42754645CD40 expression in Hodgkin's disease
Q40180827Cancer Risk After Pediatric Solid Organ Transplantation
Q42663880Cell transformation mediated by the Epstein-Barr virus G protein-coupled receptor BILF1 is dependent on constitutive signaling.
Q39539494Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils
Q61718416Chromosomal rearrangements after ex vivo Epstein–Barr virus (EBV) infection of human B cells
Q35237191Clinicopathological spectrum of Epstein-Barr virus-associated T cell malignancies
Q45787074Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease
Q45710976Comparison of Epstein-Barr Virus Presence in Hodgkin Lymphoma in Pediatric Versus Adult Argentine Patients
Q38900959Comparison of Epstein-Barr virus markers in Reed-Sternberg cells in adult Hodgkin's disease tissues from an industrialized and a developing country
Q36059593Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
Q36105462Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines.
Q37016499Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.
Q36464566Control of viral disease: the development of Epstein-Barr virus vaccines
Q41342184Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity
Q35831438Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease
Q33852518Cutaneous lymphoproliferative disorders associated with Epstein-Barr virus infection: a clinical overview
Q36399791Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease
Q36651589Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B.
Q41607034Deletion variants within the NF-kappaB activation domain of the LMP1 oncogene in acquired immunodeficiency syndrome-related large cell lymphomas, in prelymphomas and atypical lymphoproliferations
Q40848861Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease
Q42755159Demonstration of a unique Epstein-Barr virus-positive cellular clone in metachronous multiple localizations of Hodgkin's disease
Q38337443Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.
Q40684609Detection and characterization of Epstein-Barr virus in clinical specimens.
Q40994216Detection and quantification of Epstein-Barr virus EBER1 in EBV-infected cells by fluorescent in situ hybridization and flow cytometry
Q35831898Detection of Epstein-Barr virus genome in Ki-1 (CD30)-positive, large-cell anaplastic lymphomas using the polymerase chain reaction
Q37138731Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age
Q30656075Detection of Epstein-Barr virus in archival Hodgkin's disease specimens
Q45747752Detection of Epstein-Barr virus in invasive breast cancers.
Q38483042Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization.
Q45761154Determination of HLA-A*02 antigen status in Hodgkin's disease and analysis of an HLA-A*02-restricted epitope of the Epstein-Barr virus LMP-2 protein
Q35017860Diagnosis of Epstein-Barr virus-associated diseases
Q81828786Diagnostic accuracy of imprint cytology in the assessment of Hodgkin's disease in Japan
Q39658596Dynamic chromosomal rearrangements in Hodgkin's lymphoma are due to ongoing three-dimensional nuclear remodeling and breakage-bridge-fusion cycles
Q50567063EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: evidence for geographical polymorphism but not for tumour-specific subtype restriction.
Q43225878EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency
Q53024631EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products
Q33987454EBV latency types adopt alternative chromatin conformations
Q37589686EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults
Q51735191EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.
Q42911133EBV-associated recurrent Hodgkin's disease after renal transplantation
Q37268348EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
Q43790916EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru
Q45735503Editorial comment on detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction by Wagner and colleagues
Q36617871Effect of material deprivation on Epstein-Barr virus infection in Hodgkin's disease in the West Midlands
Q36207395Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice
Q38375380Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis
Q41490952Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic cells in residual germinal centres in Hodgkin's disease
Q41475508Epstein Barr virus in Argentine pediatric Hodgkin's disease
Q45788351Epstein barr virus (EBV)‐carrying cells of a chronic lymphocytic leukemia (CLL) subpopulation express EBNA1 and LMPS but not EBNA2 in vivo
Q38257974Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis
Q59354936Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice
Q45736201Epstein-Barr Virus-Associated Cholangiocarcinoma with Lymphoepithelioma-Like Component.
Q36653989Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
Q43478753Epstein-Barr virus (EBV) in Chinese pediatric Hodgkin disease: Hodgkin disease in young children is an EBV-related lymphoma
Q40958139Epstein-Barr virus (EBV) in extranodal T-cell non-Hodgkin's lymphomas (T-NHL). Identification of nasal T-NHL as a distinct clinicopathological entity associated with EBV.
Q24670596Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations
Q40126382Epstein-Barr virus (EBV) provides survival factors to EBV+ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL.
Q45746241Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1.
Q39604074Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.
Q35764233Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
Q35831567Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study
Q38322174Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells
Q33906890Epstein-Barr virus and Hodgkin's lymphoma in Cairo, Egypt
Q43049278Epstein-Barr virus and human hepatocellular carcinoma
Q56947843Epstein-Barr virus and nasopharyngeal carcinoma
Q34221194Epstein-Barr virus and oncogenesis: from latent genes to tumours
Q44909702Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma
Q40475844Epstein-Barr virus as an agent of haematological disease.
Q45748229Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population
Q36641073Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function
Q41601147Epstein-Barr virus genes and cancer cells
Q45860535Epstein-Barr virus in AIDS-related primary central nervous system lymphoma
Q45783366Epstein-Barr virus in Hodgkin's disease and site of origin of tumour
Q41979291Epstein-Barr virus in adult T-cell leukemia/lymphoma.
Q35833192Epstein-Barr virus in pyothorax-associated pleural lymphoma
Q45753650Epstein-Barr virus in the pathogenesis of Hodgkin's disease
Q35833510Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?
Q44036511Epstein-Barr virus infection and response to radiotherapy in squamous cell carcinoma of the oral cavity
Q34576340Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions
Q42451168Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia
Q38356037Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity
Q40040836Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells
Q41594644Epstein-Barr virus oncogenesis
Q40620396Epstein-Barr virus persistence and virus-associated tumours
Q45459307Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings
Q45785122Epstein-Barr virus-associated hemophagocytic syndrome
Q44406598Epstein-Barr virus-associated large granular lymphocyte leukemia with cutaneous infiltration
Q34651670Epstein-Barr virus-associated lymphomas.
Q40507895Epstein-Barr virus-associated non-Hodgkin's lymphoma in HIV-infected patients
Q35076846Epstein-Barr virus-recent advances
Q45744350Epstein-Barr virus: Co-opting B-cell memory and migration
Q34572150Epstein-Barr virus: exploiting the immune system
Q38968588Epstein-Barr virus: more than 50 years old and still providing surprises.
Q39444685Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma
Q33899102Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications
Q45789695Epstein‐Barr virus in nasal T‐cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China
Q40445894Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1.
Q36119183Evidence of an oncogenic gammaherpesvirus in domestic dogs
Q71739027Evolution of Hodgkin's disease
Q37072931Exposures to multiple pesticides and the risk of Hodgkin lymphoma in Canadian men
Q40848717Expression of B7 (CD80) and CD40 antigens and the CD40 ligand in Hodgkin's disease is independent of latent Epstein-Barr virus infection
Q43768398Expression of EBV encoded latent membrane protein 1 (LMP-1) and bcl-2 protein in childhood and adult Hodgkin's disease: application of microwave irradiation for antigen retrieval
Q42197461Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas
Q41809459Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas
Q45754776Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan.
Q45787321Expression of bcl‐2 protein and transcription of the Epstein‐Barr virus bcl‐2 homologue BHRF‐1 in Hodgkin's disease: implications for different pathogenic mechanisms
Q39610559Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus
Q72052148Expression of c‐myc and c‐ras oncogenes in the neoplastic and non‐neoplastic cells of Hodgkin's disease
Q40868229Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status
Q38462802Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells
Q28213139Fascin expression in CD30-positive cutaneous lymphoproliferative disorders
Q34435311Follicular dendritic cell sarcoma mimicking diffuse large cell lymphoma: a case report
Q92775971Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma
Q45146767Frequency of Epstein-Barr virus expression in various histological subtypes of Hodgkin's lymphoma
Q45730504Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells
Q36784912Fulminant EBV-driven CD8 T-cell lymphoproliferative disorder following primary acute EBV infection: a unique spectrum of T-cell malignancy
Q33810034Gammaherpesviruses and "Hit-and-Run" oncogenesis
Q35764932Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein
Q40489810Genetically Engineered Tumor Vaccines
Q33778708HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma
Q38330937Heat shock factor 1 upregulates transcription of Epstein-Barr Virus nuclear antigen 1 by binding to a heat shock element within the BamHI-Q promoter
Q50863201Hemophagocytic syndrome associated with hematological neoplasias.
Q41047224Hepatitis C virus and non-Hodgkin's lymphomas
Q43529854Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr virus-containing natural killer cell leukaemia/lymphoma and T-cell lymphoma; mimicking malignant histiocytosis
Q45750564High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease
Q45778505High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma
Q35832700High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin's disease
Q24535291Hodgkin's disease and the Epstein-Barr virus
Q40413265Hodgkin's disease: a monoclonal lymphoproliferative disorder?
Q41107614Hodgkin's disease: old and recent clinical concepts
Q35640337Hodgkin's lymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome
Q36564877Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs
Q35103531How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus
Q24302204Human cellular protein VRK2 interacts specifically with Epstein-Barr virus BHRF1, a homologue of Bcl-2, and enhances cell survival
Q24683663Human herpesvirus 6
Q40401808Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors
Q33640213IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter
Q45732919Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.
Q36669953Immune regulation in Epstein-Barr virus-associated diseases
Q37902694Immunocytochemistry: an indispensable technique in routine cytology
Q41217111Immunology of Hodgkin's disease
Q33561185Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034
Q56903494Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
Q36449583Immunovirology of transforming viruses
Q35395693Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases
Q42522230In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas
Q53702693In vivo production of interleukin-10 by malignant cells in AIDS lymphomas.
Q45778254Infection by Epstein-Barr virus in Hodgkin's disease is not restricted to the Reed-Sternberg cells
Q41115991Infectious agents and environmental factors in lymphoid malignancies
Q45786981Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis
Q39950750Influence of Epstein-Barr virus infection in adult T-cell leukemia
Q35892261Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.
Q39400493LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma
Q35539719LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.
Q34430225LMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells
Q36292321Lack of involvement of known oncogenic DNA viruses in Epstein-Barr virus-negative Hodgkin's disease.
Q43464160Lack of restricted T-cell receptor beta-chain variable region (V beta) usage of reactive T-lymphocytes in Hodgkin's disease
Q40912121Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease
Q36231451Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development
Q35888992Localization of predisposition to Hodgkin disease in the HLA class II region.
Q35763601Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group
Q36361402Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines
Q45737162Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin's disease in Tokyo: trend between 1955 and 1999.
Q39585366Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation
Q45770516Miliary tuberculosis in a patient with Epstein-Barr virus-associated angioimmunoblastic lymphadenopathy
Q45759860Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus
Q36464514Molecular basis for Epstein-Barr virus induced pathogenesis and disease
Q34225554Molecular virology of Epstein-Barr virus
Q72428154Monocytoid B-cells occurring in Hodgkin's disease
Q45784460Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus
Q22254088NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells
Q35938397Nasal angiocentric lymphoma with hemophagocytic syndrome
Q46826933Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy
Q28316608Neurotoxic treatment in a patient with brachial neuritis associated with Hodgkin's disease
Q35178930New Testing Approaches in Transfusion Medicine
Q35137170New candidate virus in association with Hodgkin's disease.
Q35796270New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease
Q35228687Non-Hodgkin's lymphomas and paraproteinaemias
Q37461346Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter
Q45756797Oncogene expression in tumour cells of pediatric Hodgkin's disease in Argentina--correlation with Epstein Barr virus presence.
Q64086953Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
Q60920748Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases
Q35618780Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells
Q35026045Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders
Q41217096Pathophysiology of Hodgkin's disease: functional and molecular aspects
Q41136153Pediatric cancer: environmental and genetic aspects
Q45769830Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein-Barr virus
Q39826959Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation
Q33589790Practical applications of immunohistochemistry in hematolymphoid neoplasms
Q35831247Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells
Q39992915Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma
Q35858283Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases
Q48116228Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: expression of cellular surface proteins and Epstein-Barr viral markers
Q37111224Primary cerebral lymphoma: a study of 47 cases probed for Epstein-Barr virus genome
Q35991951Primary cutaneous plasmacytoma after rejection of a transplanted kidney: case report and review of the literature
Q37741123Rare Clinical Sign of Hodgkin's Lymphoma: Ocular Involvement
Q37004635Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell
Q35239255Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material
Q42013581Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
Q36464560Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases
Q35848189Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus
Q40794281Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.
Q45785307Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression
Q36641491Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents
Q43517544Routine detection of Epstein-Barr virus specific T-cells in the peripheral blood by flow cytometry
Q37366527STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma
Q39737614Short-circuiting long-lived humoral immunity by the heightened engagement of CD40.
Q35239264Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease
Q36623552South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease
Q35609768T cell-based therapies for EBV-associated malignancies
Q37948940T-cell therapies for Epstein-Barr virus-associated lymphomas
Q45729409Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma
Q35874869The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element
Q33882153The Epstein-Barr virus and its association with human cancers
Q35576612The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates.
Q40958145The antigen-presenting cell function of Reed-Sternberg cells
Q45749636The association of latent Epstein-Barr virus infection with hydroa vacciniforme
Q41305118The association of the Epstein-Barr virus with malignant lymphoma
Q30670726The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction
Q40782239The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain
Q41036904The ecology and pathology of Epstein-Barr virus
Q41217081The epidemiology of Hodgkin's disease
Q53859468The evidence of human herpesvirus 6 infection in the lymph nodes of Hodgkin's disease.
Q34089485The expression and function of Epstein-Barr virus encoded latent genes
Q35795114The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders
Q40843575The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell
Q72341488The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood
Q36686042The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.
Q36470749The next wave of recombinant and synthetic anticancer vaccines
Q36685081The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential
Q33925488The role of EBV in post-transplant malignancies: a review
Q34798881The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas
Q41553353The role of Epstein-Barr virus in lymphoid malignancies
Q40857915The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma
Q35854017Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein
Q36135900Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells
Q34554722Treatment of Epstein-Barr virus-associated malignancies with specific T cells
Q96303449Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome
Q45772460Undifferentiated carcinoma of the parotid gland in a white patient: detection of Epstein-Barr virus by in situ hybridization
Q35798133Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia
Q39736781Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity
Q45730476Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood
Q33852513Virus-induced immune dysregulation as a triggering factor for the development of drug rashes and autoimmune diseases: with emphasis on EB virus, human herpesvirus 6 and hepatitis C virus
Q38363351Viruses and Hodgkin disease: no evidence of novel herpesviruses in non-EBV-associated lesions.
Q40486562What is the Origin of the Malignant Cell in Hodgkin's Disease?

Search more.